1 dults as a progressive spinal cord syndrome (adrenomyeloneuropathy).

2 metabolism, such as adrenoleukodystrophy and adrenomyeloneuropathy.

3 hy has two distinct neurological phenotypes: adrenomyeloneuropathy, a non-inflammatory axonopathy mos

4 had established severe motor disability from adrenomyeloneuropathy affecting only the spinal cord and

5 hich manifests as the spinal cord axonopathy adrenomyeloneuropathy (AMN) in nearly all males survivin

6                                       "Pure" adrenomyeloneuropathy (AMN) is the noninflammatory myelo

7                                     Among 68 adrenomyeloneuropathy (AMN) patients initially without c

8 ween ALD phenotypes in patients with cALD or adrenomyeloneuropathy (AMN), heterozygote female carrier

9  imaging (MRI) were evaluated in 84 men with adrenomyeloneuropathy (AMN).

10  a cross-sectional study on 13 patients with adrenomyeloneuropathy and 12 age-matched healthy control

11                                Asymptomatic, adrenomyeloneuropathy and female heterozygote patients h

12                                              Adrenomyeloneuropathy is the late-onset form of X-linked

13                            In conclusion, in adrenomyeloneuropathy patients quantitative magnetic res

14 enoleukodystrophy mouse model often have the adrenomyeloneuropathy phenotype.

15 hological features in a mouse model of human Adrenomyeloneuropathy, preceding disease-onset by one ye

16 l changes that can characterize the brain of adrenomyeloneuropathy subjects in the early stages of th

17                                           In adrenomyeloneuropathy the spinal cord is the main site o